INTERNATIONAL PATENT: SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE FILES APPLICATION FOR "MULTI-SPECIFIC IMMUNE CELL ENGAGING MOLECULES TO TREAT CD19 AND CD33 CO-EXPRESSING CANCERS"

GENEVA, May 13 -- SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (1900 Ninth AvenueSeattle, Washington 98101) filed a patent application (PCT/US2025/054051) for "MULTI-SPECIFIC IMMUNE CELL ENGAGING MOLECULES TO TREAT CD19 AND CD33 CO-EXPRESSING CANCERS" on Nov 04, 2025. With publication no. WO/2026/097097, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LOH, Mignon (c/o Seattle Children's Hospital d/b/a Seattle Children's Research Institute1900 Ninth AvenueSeattle, Washington 98101), JAMET, Sophie...